NADER EL-MALLAWANY to HIV Infections
This is a "connection" page, showing publications NADER EL-MALLAWANY has written about HIV Infections.
Connection Strength
2.348
-
Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease. JCI Insight. 2023 Nov 22; 8(22).
Score: 0.375
-
Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania. HIV Med. 2023 06; 24(6):664-675.
Score: 0.353
-
Long-term outcomes for children and adolescents with Kaposi sarcoma. HIV Med. 2022 02; 23(2):197-203.
Score: 0.324
-
KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions. Int J Cancer. 2019 01 01; 144(1):110-116.
Score: 0.264
-
Increasing Numbers of New Kaposi Sarcoma Diagnoses in HIV-Infected Children and Adolescents Despite the Wide Availability of Antiretroviral Therapy in Malawi. Clin Infect Dis. 2017 03 15; 64(6):818-819.
Score: 0.236
-
Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PLoS One. 2016; 11(4):e0153335.
Score: 0.222
-
Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries. Int J STD AIDS. 2020 07; 31(8):724-734.
Score: 0.074
-
Navigating the heterogeneous landscape of pediatric Kaposi sarcoma. Cancer Metastasis Rev. 2019 12; 38(4):749-758.
Score: 0.071
-
Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome-like Clinical Presentation in Human Immunodeficiency Virus-infected Children in Malawi. Clin Infect Dis. 2019 11 13; 69(11):2022-2025.
Score: 0.071
-
Impact of Protease Inhibitors on HIV-Associated Kaposi Sarcoma Incidence: A Systematic Review. J Acquir Immune Defic Syndr. 2018 10 01; 79(2):141-148.
Score: 0.066
-
Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol. 2018 09; 4:1-7.
Score: 0.062
-
Lessons From Pediatric HIV: A Case for Curative Intent in Pediatric Cancer in LMICs. Pediatrics. 2017 10; 140(4).
Score: 0.061
-
Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatr Blood Cancer. 2017 05; 64(5).
Score: 0.057
-
Tumoral bacillary angiomatosis in a child with human immunodeficiency virus. JAMA Dermatol. 2014 Sep; 150(9):1015-6.
Score: 0.050
-
Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana. Pediatr Blood Cancer. 2013 Aug; 60(8):1274-80.
Score: 0.045
-
Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi. Blood Adv. 2019 02 26; 3(4):612-620.
Score: 0.017